Stimcell Energetics (STME) Enterprise Value Growth (1y) (2012 - 2026)
Stimcell Energetics (STME) Enterprise Value Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -53.59% |
| Nov 30, 2025 | -36.48% |
| Aug 31, 2025 | 68.68% |
| May 31, 2025 | 66.41% |
| Feb 28, 2025 | 91.62% |
| Nov 30, 2024 | -49.50% |
| Aug 31, 2024 | 64.61% |
| May 31, 2024 | 55.83% |
| Feb 29, 2024 | -944.53% |
| Nov 30, 2023 | -27.00% |
| Aug 31, 2023 | -503.68% |
| May 31, 2023 | -303.18% |
| Feb 28, 2023 | 75.18% |
| Nov 30, 2022 | 52.05% |
| Aug 31, 2022 | 84.92% |
| May 31, 2022 | -17.48% |
| Feb 28, 2022 | -18.37% |
| Nov 30, 2021 | -70.52% |
| Aug 31, 2021 | 47.07% |
| May 31, 2021 | 53.97% |